๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
This is a randomized controlled trial in patients with a diagnosis of granu...
Status
Unknown
Location
University of South Florida TAPIR Study Team
Start Date
2014-02-17
Trial ID
NCT01933724
Treatments Being Tested
Corticosteroid therapy has always been the standard treatment for giant cel...
Status
Recruiting
Location
CHU de Caen Normandie
Start Date
2021-03-03
Trial ID
NCT04012905
Treatments Being Tested
This study will evaluate the Efficacy and Safety of Infliximab versus Cyclo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-06-11
Trial ID
NCT03088293
Treatments Being Tested
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
This multi-center center phase I/II study to establish the lowest possible ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-06-05
Trial ID
NCT05123040
Treatments Being Tested
270 untreated patients, age between 18 and 65 years , with diffuse large B-...
Status
Unknown
Location
Fourth Hospital of Hebei Medical University
Start Date
2016-11
Trial ID
NCT03022123
Treatments Being Tested
This is an open-label Phase I/II trial to assess the feasibility and safety...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2011-03
Trial ID
NCT01266317
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested